ESRRB: A Potential Drug Target and Biomarker for Orphan Nuclear Receptors

Target Name: ESRRB

NCBI ID: G2103

ESRRB

ESRRB: A Potential Drug Target and Biomarker for Orphan Nuclear Receptors

Abstract:

The orphan nuclear receptor (ESRRB) family plays a crucial role in various physiological processes in the body. Despite its importance, several orphan nuclear receptors have not yet been explored as drug targets or biomarkers. The ESRRB is a promising candidate for both applications. This article aims to provide an overview of the ESRRB, its structure, function, and potential as a drug target and biomarker.

Introduction:

Nuclear receptors are a family of transmembrane proteins that play a significant role in regulating various physiological processes in the body. These proteins are involved in signaling pathways that regulate gene expression, cell growth, and differentiation. One of the subfamilies of nuclear receptors is the ESRRB, which has been identified in various organisms. ESRRBs are characterized by the presence of a nuclear localization signal (NLS), a transmembrane segment, and a N-terminal extracellular domain.

Despite its importance in cellular signaling, the ESRRB has not yet been explored as a drug target or biomarker. Several studies have demonstrated the potential of targeting ESRRBs due to their unique structure and function. In this article, we will explore the ESRRB in greater detail, including its structure, function, and potential as a drug target and biomarker.

Structure and Function:

The ESRRB is a member of the nuclear receptor superfamily and is characterized by the presence of a NLS, a transmembrane segment, and an N-terminal extracellular domain. The NLS is a unique feature that allows the ESRRB to be targeted by small molecules. The NLS is a regions of 20-30 amino acids that are involved in the formation of a complex with a specific ligand, leading to nuclear translocation.

The ESRRB is involved in various physiological processes, including cell growth, differentiation, and signaling pathways. One of the well-studied functions of the ESRRB is its role in cell signaling. The ESRRB is involved in the regulation of cell growth, apoptosis, and autophagy. For instance, several studies have shown that the ESRRB plays a role in the regulation of cell proliferation and has been implicated in the development of various diseases, including cancer.

In addition to its role in cell signaling, the ESRRB is also involved in the regulation of gene expression. Several studies have shown that the ESRRB can interact with various transcription factors and play a role in the regulation of gene expression. This interaction between the ESRRB and transcription factors suggests that the ESRRB may be a potential drug target for various diseases.

Potential as a Drug Target:

The ESRRB is a promising candidate as a drug target due to its unique structure and function. Several studies have shown that small molecules can bind to the ESRRB NLS and induce nuclear translocation. This nuclear translocation allows the ESRRB to be easily targeted by small molecules and may facilitate the development of small molecule-based therapies for various diseases.

In addition to its potential as a drug target, the ESRRB is also involved in the regulation of cell signaling. The ESRRB is involved in the regulation of cell growth, apoptosis, and autophagy, and its dysfunction has been implicated in the development of various diseases, including cancer. Therefore, targeting the ESRRB with small molecules or other therapeutic approaches may have potential therapeutic applications for these diseases.

Potential as a Biomarker:

The ESRRB is also an attractive candidate as a biomarker for various diseases. The ESRRB is involved in the regulation of cell signaling and its dysfunction has been implicated in the development of various diseases. Therefore, measuring the levels of the ESRRB in tissues or fluids may provide valuable information about the severity of disease and the effectiveness of various therapeutic approaches.

Conclusion:

The ESRRB is a promising candidate as a drug target and biomarker due to its unique structure and function. Its involvement in cell signaling and its potential as a drug target make it an attractive target for small molecule-based therapies. Additionally, the ESRRB is also involved in the regulation of gene expression and its dysfunction has been implicated in the development of various diseases. Therefore, further research is needed to fully understand the ESRRB and its potential as a drug target and biomarker.

Protein Name: Estrogen Related Receptor Beta

Functions: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity (PubMed:17920186, PubMed:19755138). Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways. Upon FGF signaling pathway activation, interacts with KDM1A by directly binding to enhancer site of ELF5 and EOMES and activating their transcription leading to self-renewal of trophoblast stem cells. Also regulates expression of multiple rod-specific genes and is required for survival of this cell type (By similarity). Plays a role as transcription factor activator of GATA6, NR0B1, POU5F1 and PERM1 (PubMed:23836911). Plays a role as transcription factor repressor of NFE2L2 transcriptional activity and ESR1 transcriptional activity (PubMed:17920186, PubMed:19755138). During mitosis remains bound to a subset of interphase target genes, including pluripotency regulators, through the canonical ESRRB recognition (ERRE) sequence, leading to their transcriptional activation in early G1 phase. Can coassemble on structured DNA elements with other transcription factors like SOX2, POU5F1, KDM1A and NCOA3 to trigger ESRRB-dependent gene activation. This mechanism, in the case of SOX2 corecruitment prevents the embryonic stem cells (ESCs) to epiblast stem cells (EpiSC) transition through positive regulation of NR0B1 that inhibits the EpiSC transcriptional program. Also plays a role inner ear development by controlling expression of ion channels and transporters and in early placentation (By similarity)

The "ESRRB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ESRRB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets